| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
42,638 |
37,862 |
$16.19M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,859 |
26,597 |
$7.36M |
| G0378 |
Hospital observation service, per hour |
4,682 |
3,724 |
$3.67M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,600 |
7,725 |
$3.28M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,349 |
4,194 |
$929K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,401 |
2,308 |
$916K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
27,710 |
8,259 |
$857K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
580 |
541 |
$833K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,863 |
7,387 |
$722K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
43,376 |
11,053 |
$714K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,780 |
3,592 |
$620K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,181 |
4,042 |
$613K |
| OP272 |
|
5,352 |
4,284 |
$477K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,631 |
17,599 |
$446K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19,828 |
15,331 |
$437K |
| OP370 |
|
3,218 |
3,102 |
$393K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,722 |
1,632 |
$367K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,794 |
2,752 |
$350K |
| 71045 |
Radiologic examination, chest; single view |
12,145 |
11,175 |
$330K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,928 |
1,233 |
$322K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,950 |
2,781 |
$320K |
| 71046 |
Radiologic examination, chest; 2 views |
7,814 |
7,558 |
$308K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,287 |
4,946 |
$246K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,090 |
30,806 |
$234K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,440 |
2,679 |
$215K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,686 |
1,605 |
$200K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
8,447 |
2,682 |
$197K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,571 |
1,531 |
$197K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
40,258 |
32,356 |
$196K |
| 76830 |
Ultrasound, transvaginal |
1,325 |
1,295 |
$190K |
| OP259 |
|
45,004 |
30,040 |
$181K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
238 |
231 |
$179K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,901 |
3,634 |
$177K |
| 73562 |
|
2,168 |
1,994 |
$175K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,868 |
6,416 |
$155K |
| 73030 |
|
2,710 |
2,554 |
$137K |
| 97161 |
|
3,894 |
3,720 |
$137K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
277 |
271 |
$134K |
| 73610 |
|
2,741 |
2,523 |
$131K |
| 73564 |
|
2,431 |
2,271 |
$129K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,606 |
1,557 |
$125K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,274 |
4,095 |
$122K |
| 73630 |
|
3,031 |
2,825 |
$121K |
| 72110 |
|
1,356 |
1,335 |
$118K |
| OP710 |
|
1,670 |
1,649 |
$116K |
| 95957 |
|
148 |
148 |
$115K |
| 80076 |
|
27,347 |
23,986 |
$113K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,823 |
3,639 |
$113K |
| 73130 |
|
2,629 |
2,454 |
$105K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
469 |
462 |
$104K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,124 |
2,004 |
$100K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,537 |
6,055 |
$97K |
| OP258 |
|
14,693 |
11,559 |
$97K |
| 71250 |
|
697 |
669 |
$95K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,321 |
5,046 |
$91K |
| 93017 |
|
382 |
377 |
$88K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
109 |
91 |
$88K |
| 93971 |
|
864 |
841 |
$88K |
| 84484 |
|
15,083 |
12,758 |
$87K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,092 |
2,053 |
$75K |
| 97162 |
|
1,771 |
1,742 |
$73K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
895 |
867 |
$72K |
| 80320 |
|
6,507 |
5,996 |
$69K |
| 73502 |
|
1,701 |
1,592 |
$67K |
| 83880 |
|
4,777 |
4,327 |
$66K |
| 36415 |
Collection of venous blood by venipuncture |
33,454 |
26,351 |
$64K |
| 73110 |
|
1,371 |
1,273 |
$62K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,928 |
3,541 |
$62K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
42 |
40 |
$59K |
| A9270 |
Non-covered item or service |
2,426 |
1,784 |
$56K |
| 97164 |
|
1,514 |
1,439 |
$53K |
| 95816 |
|
183 |
178 |
$53K |
| 85730 |
|
14,550 |
13,413 |
$52K |
| 0240U |
|
1,449 |
1,390 |
$52K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,648 |
1,625 |
$52K |
| 85610 |
|
15,138 |
13,830 |
$49K |
| OP250 |
|
5,312 |
3,000 |
$48K |
| 90715 |
|
2,008 |
1,977 |
$47K |
| 80329 |
|
2,424 |
2,200 |
$39K |
| 70486 |
|
320 |
317 |
$35K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,264 |
3,906 |
$34K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
64 |
63 |
$34K |
| 83605 |
|
3,403 |
3,089 |
$34K |
| 72100 |
|
624 |
595 |
$32K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
92 |
91 |
$32K |
| 87040 |
|
2,940 |
2,681 |
$31K |
| 93970 |
|
215 |
208 |
$30K |
| 83735 |
|
7,561 |
6,286 |
$30K |
| 83690 |
|
10,867 |
9,818 |
$29K |
| 73590 |
|
738 |
701 |
$29K |
| 81001 |
|
14,521 |
13,603 |
$28K |
| 85027 |
|
5,228 |
4,548 |
$26K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,824 |
4,519 |
$26K |
| 80306 |
|
4,360 |
3,958 |
$26K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,634 |
1,577 |
$26K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
24 |
24 |
$23K |
| 76536 |
|
172 |
165 |
$23K |
| 70496 |
|
136 |
119 |
$22K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,620 |
1,563 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,017 |
2,003 |
$22K |
| 87070 |
|
3,151 |
3,001 |
$20K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,775 |
1,211 |
$20K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,634 |
2,133 |
$20K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,572 |
9,428 |
$20K |
| J2704 |
Injection, propofol, 10 mg |
3,729 |
3,209 |
$19K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
13 |
13 |
$19K |
| 76801 |
|
336 |
315 |
$18K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,903 |
7,509 |
$18K |
| 77080 |
|
342 |
323 |
$18K |
| 70498 |
|
123 |
107 |
$18K |
| 94664 |
|
2,330 |
1,611 |
$18K |
| 96376 |
|
794 |
769 |
$17K |
| 88342 |
|
382 |
372 |
$16K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,638 |
2,368 |
$16K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
307 |
306 |
$16K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
118 |
114 |
$15K |
| 86900 |
|
1,624 |
1,531 |
$14K |
| 87430 |
|
2,928 |
2,838 |
$14K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
339 |
337 |
$13K |
| 80053 |
Comprehensive metabolic panel |
1,560 |
1,483 |
$13K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,912 |
2,347 |
$13K |
| 96367 |
|
284 |
278 |
$13K |
| 80061 |
Lipid panel |
1,638 |
1,542 |
$13K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,482 |
3,394 |
$13K |
| J2785 |
Injection, regadenoson, 0.1 mg |
52 |
51 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,998 |
1,880 |
$12K |
| 72050 |
|
152 |
150 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,035 |
882 |
$12K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,268 |
2,080 |
$11K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$11K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
180 |
168 |
$11K |
| 81003 |
|
5,687 |
5,413 |
$11K |
| 73080 |
|
258 |
243 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,438 |
2,196 |
$10K |
| 74018 |
|
263 |
245 |
$9K |
| 82550 |
|
3,251 |
2,979 |
$9K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
82 |
55 |
$9K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
42 |
42 |
$9K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
182 |
177 |
$9K |
| J2060 |
Injection, lorazepam, 2 mg |
2,099 |
1,690 |
$8K |
| 85379 |
|
2,572 |
2,401 |
$8K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
268 |
195 |
$8K |
| 84702 |
|
1,315 |
1,178 |
$7K |
| 86901 |
|
1,639 |
1,534 |
$7K |
| 82962 |
|
6,203 |
3,842 |
$7K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
269 |
245 |
$7K |
| 85007 |
|
1,536 |
1,340 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,490 |
1,441 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
917 |
768 |
$7K |
| 87186 |
|
1,379 |
1,283 |
$7K |
| 87077 |
|
1,432 |
1,338 |
$7K |
| 86850 |
|
783 |
735 |
$7K |
| 74022 |
|
168 |
165 |
$6K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,030 |
898 |
$6K |
| 84100 |
|
1,821 |
1,428 |
$6K |
| OP229 |
|
121 |
116 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
848 |
500 |
$6K |
| 97535 |
Self-care/home management training, each 15 minutes |
300 |
210 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,422 |
1,312 |
$5K |
| 93976 |
|
66 |
64 |
$5K |
| J3490 |
Unclassified drugs |
17,457 |
10,059 |
$5K |
| 76642 |
|
47 |
45 |
$5K |
| C9113 |
Injection, pantoprazole sodium, per vial |
341 |
237 |
$5K |
| 73090 |
|
164 |
155 |
$5K |
| 84703 |
|
1,980 |
1,865 |
$5K |
| 87088 |
|
1,302 |
1,265 |
$5K |
| 94760 |
|
2,536 |
1,768 |
$4K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
206 |
109 |
$4K |
| 82803 |
|
99 |
97 |
$4K |
| J1630 |
Injection, haloperidol, up to 5 mg |
828 |
633 |
$4K |
| 82150 |
|
418 |
406 |
$4K |
| 86885 |
|
322 |
316 |
$4K |
| 86140 |
|
1,647 |
1,444 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
492 |
414 |
$3K |
| 86403 |
|
495 |
462 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
901 |
424 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
303 |
255 |
$3K |
| 85378 |
|
422 |
414 |
$2K |
| 87631 |
|
51 |
51 |
$2K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,824 |
1,363 |
$2K |
| 80164 |
|
214 |
191 |
$2K |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$2K |
| 84439 |
|
252 |
239 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
14 |
$2K |
| 12001 |
|
13 |
13 |
$2K |
| 72040 |
|
18 |
17 |
$2K |
| 29125 |
|
13 |
13 |
$2K |
| 74174 |
|
13 |
12 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,020 |
914 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,008 |
2,672 |
$2K |
| 12011 |
|
12 |
12 |
$2K |
| 88313 |
|
55 |
53 |
$1K |
| 73140 |
|
67 |
66 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
229 |
226 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
637 |
236 |
$1K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
39 |
12 |
$1K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
93 |
85 |
$964.31 |
| 76641 |
|
12 |
12 |
$958.35 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
64 |
60 |
$936.25 |
| 73552 |
|
57 |
52 |
$905.66 |
| 36591 |
|
215 |
145 |
$846.41 |
| 82607 |
|
132 |
124 |
$812.96 |
| 82728 |
|
118 |
109 |
$805.33 |
| J3480 |
Injection, potassium chloride, per 2 meq |
48 |
36 |
$799.31 |
| 72070 |
|
25 |
25 |
$780.57 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
28 |
28 |
$775.39 |
| 71101 |
|
25 |
24 |
$739.02 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
39 |
38 |
$615.33 |
| 97163 |
|
12 |
12 |
$510.65 |
| 93356 |
|
14 |
14 |
$481.89 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
25 |
$435.56 |
| 73060 |
|
14 |
12 |
$427.42 |
| 85651 |
|
179 |
174 |
$418.40 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
161 |
123 |
$417.33 |
| 85652 |
|
587 |
545 |
$412.71 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
69 |
66 |
$352.74 |
| OP637 |
|
371 |
147 |
$335.89 |
| 82746 |
|
60 |
57 |
$322.83 |
| J1956 |
Injection, levofloxacin, 250 mg |
12 |
12 |
$310.39 |
| 97116 |
|
54 |
25 |
$291.77 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
25 |
25 |
$255.09 |
| 88304 |
|
12 |
12 |
$254.20 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
61 |
60 |
$250.96 |
| 99001 |
|
73 |
73 |
$234.87 |
| 95851 |
|
46 |
41 |
$215.08 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
96 |
35 |
$211.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
47 |
38 |
$161.04 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
268 |
196 |
$133.12 |
| J3411 |
Injection, thiamine hcl, 100 mg |
14 |
13 |
$118.37 |
| 97165 |
|
26 |
25 |
$109.89 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
15 |
14 |
$100.38 |
| 83550 |
|
30 |
29 |
$97.11 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
496 |
393 |
$91.42 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$56.14 |
| 82248 |
|
18 |
16 |
$37.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$36.10 |
| 87081 |
|
16 |
16 |
$36.00 |
| 81025 |
|
19 |
19 |
$26.79 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
13 |
$15.60 |
| J7643 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
65 |
52 |
$4.94 |